NewEdge Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,684
Closed -$941K 1169
2025
Q4
$941K Buy
+2,684
New +$907K 0.01% 651
2025
Q2
Sell
-714
Closed -$311K 983
2025
Q1
$311K Buy
+714
New +$287K 0.01% 765
2024
Q4
Sell
-514
Closed -$267K 926
2024
Q3
$267K Buy
+514
New +$275K ﹤0.01% 754

Other funds holding ELV

NewEdge Wealth's ELV Position: Q1 2026 in Review

NewEdge Wealth sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 2,684 shares — an estimated $941K sold.

NewEdge Wealth first reported a position in ELV in Q3 2024 and held it in 3 quarters. The position peaked at $941K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • NewEdge Wealth reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • NewEdge Wealth sold 2,684 Elevance Health shares in Q1 2026, an estimated $941K.
  • NewEdge Wealth first reported a position in Elevance Health in Q3 2024 and held it in 3 quarters.
  • NewEdge Wealth's Elevance Health position peaked at $941K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.